Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Satraplatin Plus Prednisolone in Metastatic Hormone Refractory Prostate Cancer After Docetaxel
jRCT2080220611Phase 1
- Sponsor
- Yakult Honsha
- Start
- Sep 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of satraplatin in prostate cancer (PCa), sponsored by Yakult Honsha.
02
Drugs
satraplatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT2080220611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220611.